Cytokinetics Inc (CYTK)
Return on assets (ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -526,292 | -526,773 | -539,661 | -430,844 | -389,000 | -282,145 | -215,921 | -257,655 | -215,314 | -228,674 | -155,763 | -134,989 | -127,290 | -114,000 | -140,398 | -131,731 | -121,692 | -117,520 | -109,964 | -105,374 |
| Total assets | US$ in thousands | 824,316 | 740,614 | 779,899 | 889,815 | 1,014,780 | 1,075,960 | 771,717 | 856,253 | 841,319 | 827,539 | 564,302 | 577,062 | 533,803 | 474,112 | 232,495 | 256,582 | 289,814 | 187,393 | 198,218 | 198,611 |
| ROA | -63.85% | -71.13% | -69.20% | -48.42% | -38.33% | -26.22% | -27.98% | -30.09% | -25.59% | -27.63% | -27.60% | -23.39% | -23.85% | -24.04% | -60.39% | -51.34% | -41.99% | -62.71% | -55.48% | -53.06% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $-526,292K ÷ $824,316K
= -63.85%
Cytokinetics Inc's return on assets (ROA) has shown a declining trend over the past eight quarters, with negative values indicating that the company is generating lower profits relative to its total assets. The ROA percentages have been consistently negative, ranging from -71.12% to -26.22% during this period. This suggests that the company's ability to generate earnings from its assets has been weak and deteriorating. Further analysis and investigation into the company's operations, management decisions, and financial health may be required to understand the underlying reasons for the declining ROA and to identify potential areas for improvement.
Peer comparison
Dec 31, 2023